Lisata Therapeutics Appoints Finance Veteran Jeffrey Farrow as New Director Amid Insider Sales, Hinting at Strategic Shift and Potential Capital‑Raising Plans
Lisata Therapeutics boosts governance with finance veteran Jeffrey Farrow, aiming to drive growth in Phase 2b programs while navigating investor caution and recent volatility.
2 minutes to read